Two Sigma Advisers
VERA icon

Two Sigma Advisers’s Vera Therapeutics VERA Stock Holding History

Two Sigma Advisers’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,000
Closed -$265K – 2547
2024
Q3 		$265K Sell
6,000
-68,500
-92% -$2.6M ﹤0.01% 1964
2024
Q2 		$2.7M Buy
74,500
+14,100
+23% +$559K 0.01% 1031
2024
Q1 		$2.6M Buy
+60,400
New +$2.15M 0.01% 1089

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Two Sigma Advisers's VERA Position: Q4 2024 in Review

Two Sigma Advisers sold out of Vera Therapeutics (VERA) in Q4 2024, closing a stake of 6,000 shares — an estimated $265K sold.

Two Sigma Advisers first reported a position in VERA in Q1 2024 and held it in 3 quarters. The position peaked at $2.7M in Q2 2024. 178 funds tracked by Wall St. Rank hold VERA as of Q4 2024.

  • Two Sigma Advisers reported no remaining Vera Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Advisers sold 6,000 Vera Therapeutics shares in Q4 2024, an estimated $265K.
  • Two Sigma Advisers first reported a position in Vera Therapeutics in Q1 2024 and held it in 3 quarters.
  • Two Sigma Advisers's Vera Therapeutics position peaked at $2.7M in Q2 2024.
  • 178 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2024.

Based on Two Sigma Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.